|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2818 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/507 | (2013.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 15/00 | (2018.01) |
| (11) | Number of the document | 3263601 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17182243.0 |
| Date of filing the European patent application | 2013-10-02 | |
| (97) | Date of publication of the European application | 2018-01-03 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261708784 P | 2012-10-02 | US |
| (72) |
GRAZIANO, Robert F. , US
GUPTA, Ashok, K. , US
KIM, Su Young , US
WIGGINTON, Jon , US
|
| (73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER |
| COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER |